Citation Impact
Citing Papers
Twist Transcriptionally Up-regulates AKT2 in Breast Cancer Cells Leading to Increased Migration, Invasion, and Resistance to Paclitaxel
2007
Genetic and Functional Studies Implicate HIF1 α as a 14q Kidney Cancer Suppressor Gene
2011 StandoutNobel
Interleukin-6 in the Bone Marrow Microenvironment Promotes the Growth and Survival of Neuroblastoma Cells
2008
Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells
2009
Avogadro: an advanced semantic chemical editor, visualization, and analysis platform
2012 Standout
Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer
2019 StandoutNobel
Functional characterization of the 12p12.1 renal cancer-susceptibility locus implicates BHLHE41
2016
Treatment of kidney cancer
2009 StandoutNobel
Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma
2009
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin
2011
Renal cancer cells lacking hypoxia inducible factor (HIF)-1 expression maintain vascular endothelial growth factor expression through HIF-2
2006
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2
2007 StandoutNobel
How Good is MRI at Detecting and Characterising Cancer within the Prostate?
2006
The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
2008 StandoutNobel
AKT/PKB Signaling: Navigating Downstream
2007 Standout
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation
2008
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Stat3 Is a Negative Regulator of Intestinal Tumor Progression in ApcMin Mice
2009
Wnt signaling in cancer
2016 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
New Insights into the Biology of Renal Cell Carcinoma
2011 StandoutNobel
The von Hippel‐Lindau Tumor Suppressor Protein: An Update
2007 StandoutNobel
Cancer drug resistance: an evolving paradigm
2013 Standout
Renal-Cell Carcinoma
1996 Standout
A compendium of proteins that interact with HIF-1α
2017 StandoutNobel
Coordinated regulation of myeloid cells by tumours
2012 Standout
Measurements of T1‐relaxation in ex vivo prostate tissue at 132 μT
2012 StandoutNobel
Activation of AKT Kinases in Cancer: Implications for Therapeutic Targeting
2005
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Cancer stem cells revisited
2017 Standout
Epidemiology of Erectile Dysfunction: the Role of Medical Comorbidities and Lifestyle Factors
2005
Obesity as a Predictor of Vascular Access Outcomes: Analysis of the USRDS DMMS Wave II Study
2008
The complexity of NF-κB signaling in inflammation and cancer
2013 Standout
Phase iii randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinoma
1995
The semantics of Chemical Markup Language (CML): dictionaries and conventions
2011
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
2007 StandoutNature
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells
2013
Immunity, Inflammation, and Cancer
2010 Standout
Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression
2012 StandoutNobel
Increased activated Akt expression in renal cell carcinomas and prognosis
2008
FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma
2010
Significant Correlation between Ankle-Brachial Index and Vascular Access Failure in Hemodialysis Patients
2009
Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action
2009
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Factors affecting the patency of arteriovenous fistulas for dialysis access
2011 StandoutNobel
Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer
2017 StandoutNobel
Sexual dysfunction in the elderly: age or disease?
2005
Microenvironmental regulation of metastasis
2008 Standout
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
2014
The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition
2010
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review
2011
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
2008 Standout
A Study of Sexuality and Health among Older Adults in the United States
2007 Standout
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Cancer-related inflammation and treatment effectiveness
2014 Standout
A novel pVHL-independent but NEMO-driven pathway in renal cancer promotes HIF stabilization
2015
Multiple renal cancer susceptibility polymorphisms modulate the HIF pathway
2017 StandoutNobel
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Molecular mechanisms of mTOR-mediated translational control
2009 Standout
Prostate cancer invasion and metastasis: insights from mining genomic data
2013
Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth
2009
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
2008 Standout
TRAIL-mediated signaling in prostate, bladder and renal cancer
2011
Prognostic Nomogram for Renal Insufficiency After Radical or Partial Nephrectomy
2006
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
ZD1839 Modulates Paclitaxel Response in Renal Cancer by Blocking Paclitaxel-Induced Activation of the Epidermal Growth Factor Receptor–Extracellular Signal-Regulated Kinase Pathway
2004
Diabetic Neuropathies
2005 Standout
Association of Type and Duration of Diabetes With Erectile Dysfunction in a Large Cohort of Men
2002
Risk factors of vascular access failure in patients on hemodialysis.
2008
Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity
2004
Graft-versus-leukemia reactions after bone marrow transplantation
1990 Standout
Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens
2015
IMMUNOTHERAPY FOR METASTATIC RENAL CELL CARCINOMA
1993
pVHL suppresses kinase activity of Akt in a proline-hydroxylation–dependent manner
2016 StandoutScienceNobel
Immune Interventions in Disease
1987
mTOR pathway in renal cell carcinoma
2008
Mechanism of von Hippel-Lindau Protein-Mediated Suppression of Nuclear Factor kappa B Activity
2005
Dynamic Contrast Enhanced, Pelvic Phased Array Magnetic Resonance Imaging of Localized Prostate Cancer for Predicting Tumor Volume: Correlation With Radical Prostatectomy Findings
2006
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
The von Hippel-Lindau Tumor Suppressor Protein and Clear Cell Renal Carcinoma
2007 StandoutNobel
Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma
1999 Standout
Diabetic Autonomic Neuropathy
2003 Standout
Identification of S664 TSC2 Phosphorylation as a Marker for Extracellular Signal-Regulated Kinase–Mediated mTOR Activation in Tuberous Sclerosis and Human Cancer
2007
Adverse events associated with hormonal therapy for prostate cancer.
2005
Works of Ken Marumo being referenced
Akt activation in renal cell carcinoma: contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor
2005
STAT3, but not ERKs, mediates the IL-6–induced proliferation of renal cancer cells, ACHN and 769P
2002
Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells
2004
Increased nuclear factor-κB activation is related to the tumor development of renal cell carcinoma
2003
Erectile function and nocturnal penile tumescence in patients with prostate cancer undergoing luteinizing hormone‐releasing hormone agonist therapy
1999
The Effect of Patient Age and Other Factors on the Maintenance of Permanent Hemodialysis Vascular Access
2007
Age‐related prevalence of erectile dysfunction in Japan: Assessment by the International Index of Erectile Function
2001
Sexual behaviour and dysfunction and help‐seeking patterns in adults aged 40–80 years in the urban population of Asian countries
2005
Immunologic study of human recombinant interleukin-2 (low dose) in patients with advanced renal cell carcinoma
1989
Antitumor Effects of Interleukin 2 against Renal Cell Carcinoma: Basic Study and Clinical Application
1991
INHIBITION OF MKP-1 EXPRESSION POTENTIATES JNK RELATED APOPTOSIS IN RENAL CANCER CELLS
2004
Human lymphoblastoid interferon therapy for advanced renal cell carcinoma
1984
The Prediction of Renal Function 6 Years After Unilateral Nephrectomy Using Preoperative Risk Factors
2004
Activation of Signal Transducer and Activator of Transcription 3 in Renal Cell Carcinoma: A Study of Incidence and Its Association With Pathological Features and Clinical Outcome
2002
Elevated Akt Activation and Its Impact on Clinicopathological Features of Renal Cell Carcinoma
2003
Elevated Akt activation and its impact on clinicopathological features of renal cell carcinoma.
2003
Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer
2004
Inhibition of the ubiquitin-proteasome pathway activates stress kinases and induces apoptosis in renal cancer cells
2004